Annals of internal medicineHumansGastroesophageal RefluxCholelithiasisHypoglycemic Agents
GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo.
Kelsey L Anderson, Joseph D Feuerstein, ACP Journal Club Editorial Team at McMaster University
Published: 202610.7326/ANNALS-25-05161-JC
Abstract
CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text] Gastroenterology: [Formula: see text].